Date & Time: Friday, 25 Sep., 3:30-4:30 p.m.
Venue: Rm 202, Centre for Humanities and Social Sciences Education, NYMU
About the themeEfficient and accurate prediction of dementia such as Alzheimer’s disease in the preclinical stage is important for individual, family, social and medical reasons. In this talk, I will discuss some of the issues related to neuropsychological measurement as a key to the valid and reliable identification of persons who are at risk of developing dementia. I will also illustrate that when such efforts to more comprehensively assess neuropsychological functions are undertaken, better characterizations of spared and impaired cognitive and functional abilities result, and lead to more convincing associations with other biomarkers as well as to clinical outcomes.
About the speaker
專長：Clinical Neuropsychology／Higher cortical functioning／Use of neuroimaging(structural and functional) & behavioral paradigms to investigate individuals at high risk for Alzheimer's disease (AD) (i.e., those with Mild Cognitive Impairment and those at increased genetic risk for AD)／Cognitive function and factors related to prediction of surgical outcomes in seizure disorders／Traumatic brain injury／Brain plasticity